Vaginal microbiota in healthy pregnant women and prenatal screening of group B streptococci (GBS)

被引：39

作者：

Bayó M. ^{[1
]}

Berlanga M. ^{[2
]}

Agut M. ^{[3
]}

机构：

[1] Laboratori d'Anàlisis M. Bayó Boada, 08221 Terrassa

[2] Departament de Microbiologia i Parasitologia Sanitàries, Universitat de Barcelona

[3] Institut Químic de Sarrià, 08017 Barcelona

来源：

International Microbiology | 2002年 / 5卷 / 2期

关键词：

Group B streptococci; Pregnancy; Prenatal screening; Vaginal swabs; β-Hemolytic streptococci;

D O I：

10.1007/s10123-002-0064-1

中图分类号：

学科分类号：

摘要：

The microbiota of the lower female genital tract was evaluated from vaginal swabs obtained from 623 healthy pregnant women at gestation periods of 35-40 weeks. Isolated and identified microorganisms were expressed as percentages of total samples. As expected, lactobacilli made up the dominant vaginal microbiota (70%). Enterobacteriaceae, mainly Escherichia coli, Klebsiella spp. and Proteus, were present in 38% of the samples, which might reflect the possible contamination of vaginal tract with rectal microorganisms. Candida albicans was present in 10% of healthy pregnant woman assayed. Streptoccocci (Streptococcus sp. and Enterococcus faecalis with 3% and 4%, respectively) and other gram-positive cocci (Staphylococcus sp., 5%), along with other microorgansisms such as Gardnerella vaginalis (5%) and Pseudomonas aeruginosa (2%) may represent a potential infection risk. Streptococcus agalactiae (group B streptococci β-hemolytic, GBS) was detected in 7% of the samples. GBS infection is a leading cause of neonatal morbidity and mortality in the developed world. Furthermore, GBS was often co-isolated with C. albicans (54.5%) in the samples. A complete and detailed evaluation of the vaginal biota swab, with particular attention to the presence of potential pathogens such as GBS, is a preventive strategy that can provide useful information to obstetricians and gynecologist in managing the last days of pregnancy and delivery. © Springer-Verlag and SEM 2002.

引用

页码：87 / 90

页数：3

共 20 条

[1] Adriaanse A.H., Pel M., Bleker O.P., Semmelweis: The combat against puerperal fever, Eur J Obst Gynecol Reproduc Biol, 90, pp. 153-158, (2000)
[2] Cowan and Steel's Manual for the Identification of Medical Bacteria, 3rd Edn, pp. 50-164, (1993)
[3] Campbell J.R., Hillier S.L., Krohn M.A., Ferrieri P., Zaleznik D.F., Baker C.J., Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery, Obstet Gynecol, 96, pp. 498-503, (2000)
[4] Hospital-based policies for prevention of perinatal group B streptococcal disease: United States, 1999, Mor Mortal Wkly Rep, 49, pp. 936-940, (2000)
[5] Cotch M.F., Hillier S.L., Gibbs R.S., Eschenbach D.A., Epidemiology and outcomes associated with moderate to heavy colonization during pregnancy, Am J Obstet Gynecol, 178, pp. 374-380, (1998)
[6] Dillon H.C.J., Gray E., Pas M.A., Gray B.M., Anorectal and vaginal carriage of group B streptococci during pregnancy, J Infect Dis, 145, pp. 794-799, (1982)
[7] Gujjar P., Finucane M., Larsen B., The effect of estradiol on Candida albicans growth, Ann Clin Lab Sci, 27, pp. 151-156, (1997)
[8] Halliday E., Foote K., Dryden M., Heard M., Down R., Ward J., Universal maternal screening for neonatal group B streptococcal disease, Lancet, 356, pp. 1407-1408, (2000)
[9] Hillier S.L., Krohn M.A., Rabe L.K., Rabe L.K., Klebanoff S.J., Eschenbach D.A., The normal flora, H<sub>2</sub>O<sub>2</sub> producing lactobacilli, and bacterial vacinosis in pregnant women, Clin Infect Dis, 16, (1993)
[10] Kieran E., Matheson M., Mann A.G., Efstratiou A.A., Butler K., Gorman W., Group B sreptococcus (GBS) colonisation among expectant Irish mothers, Irish Med J, 91, pp. 21-22, (1998)

← 1 2 →